Stay updated on Locally Advanced Lung Cancer Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:51:52.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of the study title 'Phase II Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC): BTCRC-LUN16-081' and the revision number has been updated from v2.14.4 to v2.15.0. Additionally, the collaborators have been specified as Bristol-Myers Squibb and the Big Ten Cancer Research Consortium.
    Difference
    54%
    Check dated 2025-04-16T01:41:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: March 11, 2025, and February 6, 2025.
    Difference
    0.4%
    Check dated 2025-04-08T20:13:12.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T14:57:59.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated to include new results reporting dates and definitions for key clinical trial metrics, such as Progression Free Survival (PFS) and Time to Metastatic Disease (TTMD), while removing outdated information regarding recruitment status and previous reporting dates.
    Difference
    8%
    Check dated 2025-03-18T04:50:59.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:17:40.000Z thumbnail image

Stay in the know with updates to Locally Advanced Lung Cancer Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Locally Advanced Lung Cancer Immunotherapy Clinical Trial page.